GOIN KATHLEEN (Chief Operating Officer) sold 4.30K shares of PALVELLA THERAPEUTICS, INC. on the open market
Open‑market sale worth $420.0K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/23/2026ACC: 0001104659-26-006237
Officer· Chief Operating Officer
Since Feb 2026
-4.30K
Net shares
Net seller
$420.0K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
4.30K acquired · 8.60K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+2.15K
Price / share
$7.14
Trade value
$15.38K
% of position
New position
1/21/2026
0.00→2.15K
Common Stock
Direct
Shares
+2.15K
Price / share
$9.08
Trade value
$19.50K
% of position
99.7%
1/21/2026
2.15K→4.30K
Common Stock
Direct
Shares
−553.00
Price / share
$95.49
Trade value
$52.81K
% of position
12.9%
1/21/2026
4.30K→3.75K
Common Stock
Direct
Shares
−3.75K
Price / share
$97.94
Trade value
$367.18K
% of position
New position
1/21/2026
3.75K→0.00
Total
Net shares
+0.00
Net value
-$385.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | M · Option Exercise | +2.15K | $7.14 | $15.38K | New position | 0.00 | 2.15K |
| Common Stock Direct | 1/21/2026 | M · Option Exercise | +2.15K | $9.08 | $19.50K | 99.7% | 2.15K | 4.30K |
| Common Stock Direct | 1/21/2026 | S · Sale | −553.00 | $95.49 | $52.81K | 12.9% | 4.30K | 3.75K |
| Common Stock Direct | 1/21/2026 | S · Sale | −3.75K | $97.94 | $367.18K | New position | 3.75K | 0.00 |
| Total | +0.00 | -$385.10K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.15K shares
Shares
−2.15K
Strike price
7.14
Held after
19.40K
Exercisable
—
1/21/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.15K shares
Shares
−2.15K
Strike price
9.08
Held after
19.33K
Exercisable
—
1/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.15K shares | 1/21/2026 | M · Option Exercise | −2.15K | 7.14 | — | 19.40K |
| Stock Option (Right to Buy) Direct | Common Stock2.15K shares | 1/21/2026 | M · Option Exercise | −2.15K | 9.08 | — | 19.33K |